NRGN and Parkinson disease: Neurogranin, a postsynaptic protein modulating calmodulin and synaptic plasticity, was significantly elevated in AD patients compared to PSP, PD, DLB, bvFTD, and PPA patients and a non-neurodegenerative cognitively impaired group.